F/m Emerald Life Sciences Innovation ETF Rating $45.14 -0.32 (-0.70%) As of 07/24/2026 03:51 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.82Holdings in LFSC have an aggregate rating of Moderate Buy based on 338 analyst ratings issued in the past year covering 25 companies (91.3% of the portfolio).LFSC Aggregate Price Target$45.14High Prediction$45.14Average Prediction$45.14Low Prediction$45.14Holdings in LFSC have an aggregate price target of $45.14 and a range of $45.14 to $45.14 covering 25 companies (91.3% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 LFSC Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.90%TVTXTravere Therapeutics$57.36+1.2%1.9176 of 5 stars2.69$52.08 -9.2%13News CoveragePositive News7.24%COGTCogent Biosciences$39.76-1.2%1.7949 of 5 stars2.85$45.90 15.4%13News CoveragePositive News6.91%SYRESpyre Therapeutics$102.13+2.1%1.7067 of 5 stars2.92$101.42 -0.7%136.77%LIVNLivaNova$78.19-0.5%2.0136 of 5 stars2.73$81.38 4.1%11News CoveragePositive NewsAnalyst Upgrade5.83%GHGuardant Health$147.33-1.9%3.1621 of 5 stars2.96$160.04 8.6%25News CoveragePositive NewsUpcoming Earnings5.45%CORTCorcept Therapeutics$95.36-1.3%2.2498 of 5 stars2.75$88.83 -6.8%8News CoverageUpcoming Earnings5.23%MIRMMirum Pharmaceuticals$113.03-1.2%2.8946 of 5 stars2.93$143.40 26.9%15Upcoming Earnings4.12%CYTKCytokinetics$80.74-1.4%3.5106 of 5 stars2.91$99.90 23.7%22News CoveragePositive News4.07%BLLNBilliontoone$126.08-2.2%2.1383 of 5 stars2.50$126.00 -0.1%103.61%TRVITrevi Therapeutics$17.53+2.0%3.4735 of 5 stars3.00$24.91 42.1%12News CoverageAnalyst Downgrade3.54%UTHRUnited Therapeutics$528.47-0.2%4.697 of 5 stars2.85$648.33 22.7%13News CoveragePositive NewsAnalyst Forecast3.32%MANEVeradermics$109.82-5.2%2.7292 of 5 stars2.67$153.00 39.3%93.24%SVRASavara$5.51-4.2%1.8304 of 5 stars2.88$10.14 84.1%8News Coverage3.05%NKTRNektar Therapeutics$70.72+2.0%2.6182 of 5 stars2.75$150.00 112.1%12News CoverageAnalyst ForecastGap Up2.67%DNTHDianthus Therapeutics$103.87-0.9%2.2903 of 5 stars2.93$117.82 13.4%14News CoveragePositive News2.54%AXSMAxsome Therapeutics$241.00-0.2%2.7174 of 5 stars2.91$261.48 8.5%23Positive News2.38%TMDXTransMedics Group$72.26+1.6%4.7093 of 5 stars2.38$134.50 86.1%13News CoveragePositive NewsUpcoming EarningsAnalyst Forecast2.18%VRDNViridian Therapeutics$19.27+0.1%3.8836 of 5 stars2.86$38.79 101.3%14Positive News2.07%CRVSCorvus Pharmaceuticals$13.07-4.5%2.9423 of 5 stars2.71$33.33 155.0%7News CoveragePositive News2.02%ICUIICU Medical$157.44+2.6%3.1909 of 5 stars3.11$172.00 9.2%9Positive NewsAnalyst Forecast2.01%PVLAPalvella Therapeutics$138.01-3.6%3.6354 of 5 stars2.94$199.53 44.6%16Positive NewsAnalyst Forecast1.40%CBLLCeriBell$16.91+3.9%3.1229 of 5 stars2.83$22.20 31.3%6Positive News1.30%TWSTTwist Bioscience$90.27-2.3%1.5508 of 5 stars2.70$90.30 0.0%10Positive News1.26%HNGEHinge Health$74.21-3.2%4.1584 of 5 stars2.95$84.27 13.6%19Analyst Forecast1.16%BBIOBridgeBio Pharma$84.02+1.3%2.9779 of 5 stars2.83$95.21 13.3%23Positive News This page (NASDAQ:LFSC) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFSC Stock Alerts